"Histamine Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.
| Descriptor ID |
D006633
|
| MeSH Number(s) |
D27.505.519.625.375.425 D27.505.696.577.375.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Histamine Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Histamine Antagonists".
This graph shows the total number of publications written about "Histamine Antagonists" by people in this website by year, and whether "Histamine Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Histamine Antagonists" by people in Profiles.
-
Janeczko P, Norris MR, Bielory L. Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease. Curr Opin Allergy Clin Immunol. 2021 10 01; 21(5):480-485.
-
Kimchi N, Bielory L. The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Curr Opin Allergy Clin Immunol. 2020 08; 20(4):414-420.
-
Bielory L, Schoenberg D. Emerging Therapeutics for Ocular Surface Disease. Curr Allergy Asthma Rep. 2019 02 28; 19(3):16.
-
Steinweg SA, Gaspari AA. Rituximab for the Treatment of Recalcitrant Chronic Autoimmune Urticaria. J Drugs Dermatol. 2015 Dec; 14(12):1387.
-
Bielory L. A 37-year-old man referred for assistance with persistent asthma, atopic dermatitis, and chronic conjunctivitis. Ann Allergy Asthma Immunol. 2014 Apr; 112(4):290-5.
-
Bielory L, Meltzer EO, Nichols KK, Melton R, Thomas RK, Bartlett JD. An algorithm for the management of allergic conjunctivitis. Allergy Asthma Proc. 2013 Sep-Oct; 34(5):408-20.
-
Wade L, Bielory L, Rudner S. Ophthalmic antihistamines and H1-H4 receptors. Curr Opin Allergy Clin Immunol. 2012 Oct; 12(5):510-6.
-
Campbell KL, Cohn JR, Fischman DL, Walinsky P, Mallya R, Jaffrani W, Savage MP. Management of clopidogrel hypersensitivity without drug interruption. Am J Cardiol. 2011 Mar 15; 107(6):812-6.
-
Weinstein ME, Wolff AH, Bielory L. Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis. Ann Allergy Asthma Immunol. 2010 Jun; 104(6):518-22.
-
Origlieri C, Bielory L. Emerging drugs for conjunctivitis. Expert Opin Emerg Drugs. 2009 Sep; 14(3):523-36.